Flow Cytometry Market Is Projected To Witness Growth Based On Rising Demand For Point-Of-Care Testing In Chronic Diseases Management Till 2025: Grand View Research, inc.
The global flow cytometry market is expected to reach USD 8.0
billion by 2025, according to a new study by Grand View Research, Inc. The
increasing incidence of infectious diseases and cancer is expected to upsurge
the demand for flow cytometers for use in disease diagnosis over the coming
years. In addition, higher number of physicians is inclined toward the usage of
autologous and allogenic stem cell therapy, due to adverse effects caused by
chemotherapy & radiation therapy in the treatment of cancer, thereby
affecting the growth of this market.
Moreover, rising demand for
point-of-care testing in chronic diseases management is expected to fuel the
demand for cytometry techniques. Rising implementation of microfluidic
miniature flow cytometry in point-of-care diagnostics is the factor augmenting
the future growth. Increasing R&D initiatives by various key players for
the development of multicolor assays and advanced reagents for analysis are
anticipated to boost the usage rate. Advancement in technology for the purpose
of enhanced accuracy, portability, and cost-effectiveness is expected to serve
this market with lucrative growth opportunities.
Small-size high-throughput
cytometers are expected to gain popularity over the coming years due to
associated benefits such as ease in use and cost-effectiveness. Furthermore,
improvement in fluorescent dyes & introduction of bench top cytometers are
the other growth propellers. For instance, multicolor flow cytometry coupled
with multiple lasers is the fastest growing application segment, which finds
extensive applications in the field of R&D innovations in new drug
development and is adopted by many contract research organizations.
U.S. flow cytometry market, by
application, 2014-2025 (USD Million)
Browse full research report on
Flow
Cytometry Market
Further key findings from
the report suggest:
- Bead-based
flow cytometry is anticipated to witness lucrative growth rate over the
forecast period owing to increasing advancement in molecular engineering
& monoclonal antibody production
- Reagents
& consumables are expected to be the fastest growing segment as of
2016 due to extensive utilization in molecular diagnostics
- Clinical
diagnosis market is driven by factors such as increasing demand for
cost-effective disease diagnosis and associated benefits of these assays
in disease detection
- The largest
market share of commercial organizations can be attributed to the rising
large-scale production of proteins, cell line development, and other
biologicals coupled with the growing demand for cell sorting and analysis
techniques
- Asia Pacific
regional market is presumed to witness the fastest growth owing to
increasing supportive government initiatives for flourishing biotech
industry coupled with growing awareness about the applications of flow
cytometers
- Multinational
players collaborating with local diagnostic companies and healthcare
institutions in developing countries such as India & Brazil, target
the disease population and are expected to increase market penetration
For
more information: http://www.grandviewresearch.com
Comments
Post a Comment